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Abstract
Purpose/Objectives—Systematically summarize findings from research conducted on adult 
acute leukemia survivors as they relate to symptoms and quality of life (QOL).
Data Sources—Systematic review of the literature from 1990–2013 found in the PubMed, 
PsycINFO®, EMBASE, and CINAHL® databases, as well as manual searches.
Data Synthesis—The review identified 16 quantitative studies and 1 qualitative study published 
from 1990–2013 that used a self-reported QOL or symptom questionnaire. Fatigue was the most 
commonly assessed and reported symptom, followed by depression.
Conclusions—Acute leukemia and its treatment have a significant impact in all QOL domains. 
Future studies should include longitudinal research, more than one recruitment site, increased 
minority representation, and home-based exercise interventions as ways to improve all domains of 
QOL.
Implications for Nursing—This review increases awareness of commonly reported symptoms 
faced by adults with acute leukemia. Oncology nurses are central in monitoring and reporting 
symptoms to the interdisciplinary team that may contribute to changes in function, with the overall 
goal of optimizing QOL over time.
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Leukemia has little age predilection; individuals have been diagnosed with the disease at 
various stages of life. Leukemia is a group of diseases that arise from the abnormal 
proliferation of mature myeloid and lymphocytic cells (National Cancer Institute [NCI], 
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2014c). Four types of leukemia exist: acute myelogenous leukemia (AML), acute 
lymphoblastic leukemia (ALL), chronic myelogenous leukemia, and chronic lymphoblastic 
leukemia (CLL). The term acute leukemia includes both AML and ALL. Acute leukemia is 
the most common hematologic cancer in the United States, with 21,800 new diagnoses and 
11,900 deaths in 2014 (NCI, 2014a, 2014b). In 2011, an estimated 302,800 people were 
living with leukemia in the United States (NCI, 2014c). The five-year survival rate of a 
patient with leukemia is 57% (NCI, 2014c). AML and ALL are both commonly diagnosed 
in adults (NCI, 2014a, 2014b).
Acute leukemia presents aggressively, requiring intensive chemotherapy and prolonged 
hospital stays (Xuereb & Dunlop, 2003). Over time, gradual improvements have been made 
in remission and survival rates among adults with acute leukemia, but few treatment options 
exist, particularly for adults aged 60 years and older (Hiddemann et al., 1999; Stone, 2002). 
For adults with acute leukemia, induction chemotherapy is administered in the hospital 
during a three- to four-week stay. Expected treatment-related complications and symptoms 
include bone marrow suppression, neutropenic fever, and mucositis (Klepin et al., 2011; 
Stone, 2002). Symptoms are multidimensional, multiplicative in nature, and can occur solely 
or concurrently (Cleeland, 2007; Dodd et al., 2001). Symptoms are distressing and can 
disrupt activities of daily living, in addition to physical, social, emotional, and spiritual 
quality-of-life (QOL) domains. Albrecht (2014) conducted an integrative literature review of 
studies on adult acute leukemia survivors focused on physiologic and psychological 
symptoms and found variations in symptom severity and frequency. The current study builds 
on that review by summarizing findings of research conducted on adults with acute leukemia 
as they relate to symptoms and QOL, as reported directly by them.
Methods
Search Strategy
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
([PRISMA], 2014) guidelines, the first and third authors of this article conducted a 
systematic literature search to identify studies published from 1990–2013. Hand searches of 
the references of selected articles also were conducted. The following words and 
combinations were used to conduct searches in PubMed, PsycINFO®, EMBASE, and 
CINAHL®: acute leukemia, leukemia acute, acute leukeamia, health related, health-related, 
symptom, symptoms, quality of life, function, functional, well being, well-being, and 
outcome assessment.
Inclusion and Exclusion Criteria
All retrospective, prospective, cross-sectional, exploratory, observational, qualitative, 
longitudinal, and randomized, controlled trial (RCT) studies using self-reported QOL or 
symptom instruments were eligible for inclusion. The search was limited to studies reported 
in English and with adults aged 18 years or older. The resulting group of studies looked at 
survivors undergoing treatment, survivors after induction treatment, and long-term survivors. 
Studies on survivors after hematopoietic stem cell transplantation were not included because 
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of the complexity and toxicity of this treatment modality. Exclusions included case reviews, 
summary reports, clinical reviews, and literature and systematic reviews (see Figure 1).
The search resulted in 94 articles from the databases and 21 articles identified by hand 
search. Of those, 10 were duplicate articles and were removed. An additional 14 of the 105 
remaining studies were excluded based on an initial review of the title and abstracts that 
determined them to be irrelevant, leaving a total of 91 articles. Of the remaining articles, 74 
were excluded because no QOL or symptom instruments were used and the age groups or 
publication types were outside the scope of this review. The final sample included 17 articles 
composed of 16 quantitative and 1 qualitative study.
Data Extraction
After the search for and selection of articles for review, two authors (ALB and AW) 
reviewed the identified articles and checked for inclusion criteria. They each examined the 
type of study, characteristics of the sample, and use of a QOL instrument to ensure 
inclusion. In case of a disagreement, the opinion of a third researcher (BBR) was accepted as 
the criterion for the articles’ inclusion or exclusion.
General Characteristics of Quality-of-Life Studies
Characteristics of the reviewed studies are summarized in Appendix A. One study used the 
term health-related quality of life (HRQOL), 13 studies used the term QOL, and 2 used 
neither terminology. For consistency, the term QOL is used throughout the current article. 
For the two studies that used neither terminology, they were included in the final sample 
based on their use of symptom instruments. The reviewed studies used eight measures to 
assess QOL or HRQOL (Functional Assessment of Cancer Therapy–General [FACT-G], 
Functional Assessment of Cancer Therapy–Spiritual [FACT-Sp], Functional Assessment of 
Cancer Therapy–Fatigue [FACT-F], SF-36®, Perceived QOL [PQOL], European 
Organisation for the Research and Treatment of Cancer Quality-of-Life Questionnaire–Core 
30 [EORTC QLQC30], Schedule for the Evaluation of Individual QOL [SEIQOL], and the 
SEIQOL–Direct Weighting).
A survivor is defined as “from the time of diagnosis, through the balance of his or her life” 
(National Coalition for Cancer Survivorship, 2004, p. 1). Family members, friends, and 
caregivers also are impacted by the survivorship experience and are, therefore, included in 
this definition (National Coalition for Cancer Survivorship, 2004). The current article is a 
systematic review of existing literature and the terminology used in each individual article 
will be used. Some authors refer to those undergoing treatment as “patients,” “participants,” 
or “survivors.” The terminology used by the original author will be retained to best convey 
his or her meaning.
Eleven of the quantitative studies and the qualitative study were published more than five 
years ago. Eleven of the studies were conducted outside of the United States. One study used 
a sample from Portugal and the United States to present an international comparison of QOL 
(Forjaz & Guarnaccia, 2001). Sample sizes were fairly small, ranging from 10–479 adults, 
with a mean age of 59 years. Across all studies, more participants were male, which is 
consistent with prevalence rates for acute leukemia. All of the examined studies recruited 
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convenience samples from multiple cancer center sites. Eight studies focused on mixed solid 
and non-solid tumors, and the remaining focused on acute leukemia only (n = 9). The 
current authors could not separate the data in articles that used a mixed population because 
of the small sample sizes of survivors with leukemia. The findings from eight mixed 
populations support the conclusion that symptoms and QOL are similar to those in the eight 
acute leukemia-only studies. A quantitative approach with a cross-sectional design was used 
in five studies, seven used a longitudinal design, two were of exercise interventions, and two 
had observational designs. One study used a mixed-methods design (Persson, Larsson, 
Ohlsson, & Hallberg, 2001).
Impact of Acute Leukemia on Physical, Psychosocial, and Spiritual Well-Being
The findings presented in this review address the impact of treatment on acute leukemia 
symptoms and physical well-being. In addition, the impact of treatment on psychological 
and spiritual well-being will be described.
The most common, standard treatment for de novo acute leukemia is intensive 
chemotherapy, which has short- and long-term physical and psychological effects on QOL 
(Mayer et al., 1994; Stone & Mayer, 1993). The short-term effects of intensive 
chemotherapy on QOL, fatigue, and physical function in survivors with AML are described 
as fairly stable over time and similar in younger (aged 18–59 years) and older (aged 60 years 
and older) adults (Mohamedali et al., 2012). In addition, physical function generally 
improved over time, but the improvement was somewhat greater in younger adults. 
Compared to younger adults, older adults tolerated intensive chemotherapy relatively well, 
as evidenced by little variation in QOL and physical function scores (Mohamedali et al., 
2012).
In Stalfelt (1994), most patients were physically and psychologically affected during the 
induction period, particularly during week 3 of their hospitalization. One symptom that 
improved over time was nausea. Schumacher, Kessler, Buchner, Wewers, and van de Loo 
(1998) supported the finding that patients tended to suffer less from fatigue, nausea and 
emesis, loss of appetite, and sleep disturbance (p = 0.001) by the end of their treatment. 
Another study showed that 86% of survivors rated their health as good after discharge from 
the hospital following intensive care for life-threatening medical complications (Yau, 
Rohatiner, Lister, & Hinds, 1991). None of the survivors reported increased limitations in 
their daily activities, and 71% had returned to full-time employment.
One comparative study explored similarities and differences in physical QOL in 98 
Portuguese and 109 American outpatient survivors (Forjaz & Guarnaccia, 2001). The article 
did not specify the type of hematologic malignancy. Overall, Portuguese survivors reported 
better physical functioning, less pain, more vitality, better social functioning, and better 
general QOL than the American survivors. Portuguese survivors tended to be older (X̅ age = 
55.3 years, SD = 17.4, p = 0.0007) than American survivors (X ̅ age = 48.9 years, SD = 
16.3). Forjaz and Guarnaccia (2001) found that age and QOL vary among ethnic and racial 
groups and should be explored further.
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Impact of Treatment and Acute Leukemia on Psychological and Spiritual Well-Being
Acute leukemia may have a negative psychological effect on survivors at the time of 
diagnosis and throughout their illness. Long-term survivors of acute leukemia (X ̅ = 5.6 
years) had higher distress scores on the Brief Symptom Inventory compared to Hodgkin 
lymphoma survivors (X̅ = 5.9 years), suggesting acute leukemia survivors experienced late 
symptom effects (Kornblith et al., 1998). Moderate-to-strong correlations were found 
between fatigue scores and depression scores in cross-sectional (Alibhai et al., 2012) and 
longitudinal studies (Alibhai, Leach, Kermalli, et al. 2007; Alibhai, Leach, Kowiger, et al., 
2007; Battaglini et al., 2009).
Literature is lacking on long-term survivors’ symptoms and QOL in adults with acute 
leukemia. Overall, QOL improved over time for survivors with AML in all domains, 
including role functioning, emotional functioning (p = 0.001), and social functioning (p = 
0.007) from the time of induction chemotherapy to the end of treatment. For patients who 
relapsed, QOL was lower with more symptoms experienced at the start of treatment 
compared to patients who had not relapsed (Persson et al., 2001).
Emotional functioning had the greatest improvement among all QOL domains in a study by 
Alibhai et al. (2012). Those who survived for more than two years experienced a change of 
attitude about what was important in their lives, but reverted to their earlier lifestyles within 
two years after treatment (Stalfelt, 1994). Anxiety and depressive symptoms are experienced 
by patients during treatment, and they also exhibit posttraumatic stress disorder symptoms, 
including high incidence of intrusive thoughts and avoidance. The findings were similar to 
those of Montgomery, Pocock, Titley, and Lloyd (2003), where 51% of patients with 
leukemia had distress and mild-to-moderate depression across their illness journey (from 
one month to eight years).
Patients at two years post-treatment felt that their QOL improved after entering remission, 
and their experiences were categorized into one of two themes: (a) believed in life, fought 
for it, and came through stronger, or (b) life went on, adapted, and found a balance in the 
new life (Persson & Hallberg, 2004). Most patients found benefits in this new value they 
placed on life; they readjusted priorities and enjoyed life more intensely, which outweighed 
the adverse effects of their treatments and remission status (Schumacher et al., 1998). A few 
patients reported poorer psychological QOL after entering remission, and their responses 
were categorized into the theme of “life was over, felt out of control, and lost belief in life” 
(Persson et al., 2001).
Only one study focused on spirituality as a QOL domain. Pearce, Coan, Herndon, Koenig, 
and Abernethy (2012) explored whether oncology inpatients (N = 150) in a malignant 
hematology and solid tumor oncology unit received spiritual care consistent with their 
needs, and, if they were inconsistent, whether the patients experienced deleterious effects on 
their outcomes. The majority of patients, 91%, expressed spiritual needs, and 67% received 
spiritual care from their healthcare providers. However, a subset (17%) received less 
spiritual care than desired from their healthcare providers. Those whose spiritual needs were 
not met reported more depressive symptoms, less meaning, and less peace about their lives. 
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The study findings support that spirituality is an important QOL domain and spiritual needs 
should be addressed.
Discussion
Fatigue, depression, and anxiety are more prominent symptom concerns for survivors of 
acute leukemia because they interfere with survivors’ activities of daily living and ability to 
carry out social roles. In the current study, the authors assessed symptoms solely, not 
concurrently as symptom clusters (two or more symptoms occurring together) (Kim, 
McGuire, Tulman, & Barsevick, 2005). Assessing and understanding the symptom 
experience of the adult with acute leukemia is important to determine which symptoms are 
most troublesome during and after treatment and to appropriately intervene.
Symptoms can significantly affect QOL and activities of daily living, and intensity can be 
particularly severe during chemotherapy. Fatigue is a common, tenacious symptom that 
affects the majority of cancer survivors and has been identified as more difficult to treat than 
pain (Sekeres & Stone, 2002). The majority of all the reviewed studies measured fatigue 
with one or more fatigue scales at various points during and after treatment. Overall, fatigue 
improved over time from the start of treatment to the end of the study, but future studies that 
follow survivors for a longer period of time (more than two years) may help elucidate the 
late effects of treatment.
Understanding the experiences of an adult acute leukemia survivor from the start of 
treatment through the balance of his or her life provides trajectory data on how symptoms 
and QOL vary across the continuum. One limitation of the review was not including non-
English articles and non-English instruments. Inclusion may have provided additional 
diverse, demographic, symptom, and QOL data on adults with acute leukemia.
The knowledge gaps in this area include underrepresentation of minorities, a lack of 
longitudinal studies or the use of theoretical or conceptual frameworks, and a lack of 
literature on long-term survivors’ needs. The studies include patients’ symptoms from start 
of treatment to long-term survivors, with varying symptoms across the illness journey.
One qualitative study was included in this review. Because qualitative studies allow 
survivors to express their experiences more thoroughly, using them would increase 
understanding of the subjective nature of the impact of acute leukemia and the impact that 
treatments has on patients’ lives. Using qualitative methods to complement standardized 
QOL-related instruments would more adequately capture the totality of a survivor’s 
experience than one measure alone. Additional studies could enhance the voice of the 
survivor through furthering the understanding of how symptoms affect all domains of QOL 
for this population. Although most of the reviewed studies focused on physical, 
psychological, and functional QOL and symptoms, only one study specifically measured 
spiritual QOL (Pearce et al., 2012), and only one addressed social QOL, specifically about 
returning to full-time employment (Yau et al., 1991).
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Implications for Nursing Practice
This review increases awareness of commonly reported symptoms faced by adults with acute 
leukemia. Oncology nurses are central in reporting symptoms and changes in function to the 
provider, with the aim of ultimately improving QOL. In the 2013 Advanced Oncology 
Nursing Research national survey, the top priorities rated by oncology nurses were self-
management interventions to improve symptom control, symptom management 
interventions, and interventions with technology to address symptoms (LoBiondo-Wood et 
al., 2014). The Oncology Nursing Society’s Putting Evidence Into Practice resources should 
be considered for symptoms such as depression and fatigue, the two most common 
symptoms presented in this review. Cognitive behavioral interventions or approach, 
mindfulness-based stress reduction, psychoeducational interventions, and exercise have been 
recommended for practice for survivors with depression and fatigue (Fulcher, Kim, Smith, & 
Sherner, 2014; Mitchell et al., 2014).
Conclusions
Future studies on QOL domains throughout the treatment course should include longitudinal 
designs, more than one recruitment site, and increased minority representation. Spiritual and 
social QOL are important aspects of QOL that often are the least reported and studied, as 
this current review supports. Studies with larger, diverse samples are needed to improve the 
understanding of the various QOL domains that impact overall health and survival. Future 
studies exploring the trajectories of symptoms and QOL in adult survivors will provide 
important data for interventional work.
Acknowledgments
This study was supported, in part, by grants from the National Cancer Institute (No. 5R25CA116339) and the 
American Cancer Society (No. DSCNR-13-276-03). The study also was supported, in part, by the Jonas Nurse 
Leaders Scholar Program. Bryant can be reached at ashley_bryant@unc.edu, with copy to editor at 
ONFEditor@ons.org.
References
Albrecht T. Physiologic and psychological symptoms experienced by adults with acute leukemia: An 
integrative literature review. Oncology Nursing Forum. 2014; 41:286–295. DOI: 10.1188/14.ONF.
286-295 [PubMed: 24769593] 
Alibhai S, Leach M, Kermalli H, Gupta V, Kowiger M, Tomlinson G, Minden MD. The impact of 
acute myeloid leukemia (AML) and its treatment on quality of life and functional status in older 
adults. Critical Reviews in Oncology/Hematology. 2007; 64:19–30. DOI: 10.1016/j.critrevonc.
2007.07.003 [PubMed: 17765568] 
Alibhai S, Leach M, Kowiger ME, Tomlinson GA, Brandwein JM, Minden MD. Fatigue in older 
adults with acute myeloid leukemia: Predictors and associations with quality of life and functional 
status. Leukemia. 2007; 21:845–848. [PubMed: 17287855] 
Alibhai S, O’Neill S, Fisher-Schlombs K, Breunis H, Brandwein J, Timilishain N, Culos-Reed S. A 
clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) 
undergoing induction chemotherapy. Leukemia Research. 2012; 36:1255–1261. DOI: 10.1016/
j.leukres.2012.05.016 [PubMed: 22726923] 
Battaglini CB, Hackney AC, Garcia R, Groff D, Evans E, Shea T. The effects of an exercise program in 
leukemia patients. Integrative Cancer Therapies. 2009; 8:130–138. DOI: 
10.1177/1534735409334266 [PubMed: 19679621] 
Bryant et al. Page 7













Cleeland CS. Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. 
Journal of the National Cancer Institute. Monographs. 2007; 37:16–21. DOI: 10.1093/
jncimonographs/lgm005
Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphries J, Taylor D. Advancing the science 
of symptom management. Journal of Advanced Nursing. 2001; 33:668–676. DOI: 10.1046/j.
1365-2648.2001.01697.x [PubMed: 11298204] 
Efficace F, Cartoni C, Niscola P, Tendas A, Meloni E, Scarmucci L, Mandelli F. Predicting survival in 
advanced hematologic malignancies: Do patient-reported symptoms matter? European Journal of 
Haematology. 2012; 89:410–416. DOI: 10.1111/ejh.12004 [PubMed: 22985353] 
Forjaz M, Guarnaccia C. A comparison of Portuguese and American patients with hematological 
malignancies: A cross-cultural survey of health-related quality of life. Psycho-Oncology. 2001; 
10:251–258. DOI: 10.1002/pon.522 [PubMed: 11351377] 
Fulcher CD, Kim HJ, Smith PR, Sherner TL. Putting Evidence Into Practice: Evidence-based 
interventions for depression. Clinical Journal of Oncology Nursing. 2014; 18(Suppl. 3):S26–S37. 
DOI: 10.1188/14.CJON.S3.26-37
Hiddemann W, Kern W, Schoch C, Fonatsch C, Heinecke A, Wormann B, Buchner T. Management of 
acute leukemia in elderly patients. Journal of Clinical Oncology. 1999; 17:3569–3579. [PubMed: 
10550156] 
Kim HJ, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: Concept analysis and clinical 
implications for cancer nursing. Cancer Nursing. 2005; 28:270–282. DOI: 
10.1097/00002820-200507000-00005 [PubMed: 16046888] 
Klepin HD, Geiger A, Tooze J, Kritchevsky SB, Williamson J, Pardee TS, Powell B. The feasibility of 
inpatient geriatric assessment for older adults receiving induction chemotherapy for acute 
myelogenous leukemia. Journal of American Geriatrics Society. 2011; 59:1837–1846. DOI: 
10.1111/j.1532-5415.2011.03614.x
Kornblith A, Herndon J, Zuckerman E, Cella D, Cherin E, Wolchok S, Holland J. Comparison of 
psychosocial adaptation of advanced stage Hodgkin’s disease and acute leukemia survivors. 
Annals of Oncology. 1998; 9:297–306. DOI: 10.1023/A:1008297130258 [PubMed: 9602264] 
LoBiondo-Wood G, Brown CG, Knobf MT, Lyon D, Mallory G, Mitchell SA, Fellman B. Priorities for 
oncology nursing research: The 2013 national survey. Oncology Nursing Forum. 2014; 41:67–76. 
DOI: 10.1188/14.ONF.67-76 [PubMed: 24368240] 
Mayer R, Davis RB, Schiffer C, Berg D, Powell B, Frei E. Intensive postremission chemotherapy in 
adults with acute myeloid leukemia. New England Journal of Medicine. 1994; 331:896–903. DOI: 
10.1056/NEJM199410063311402 [PubMed: 8078551] 
Mitchell SA, Hoffman AJ, Clark JC, DeGennaro RM, Poirier P, Robinson CB, Weisbrod BL. Putting 
Evidence Into Practice: An update of evidence-based interventions for cancer-related fatigue 
during and following treatment. Clinical Journal of Oncology Nursing. 2014; 18(Suppl. 3):S38–
S58. DOI: 10.1188/14.CJON.S3.38-58
Mohamedali H, Breunis H, Timilshina N, Brandwein J, Gupta V, Li M, Alibhai S. Older age is 
associated with similar quality of life and physical function compared to younger age during 
intensive chemotherapy for acute myeloid leukemia. Leukemia Research. 2012; 36:1241–1248. 
DOI: 10.1016/j.leukres.2012.05.020 [PubMed: 22727251] 
Montgomery C, Pocock M, Titley K, Lloyd K. Individual quality of life in patients with leukemia and 
lymphoma. Psycho-Oncology. 2002; 11:239–243. DOI: 10.1002/pon.557 [PubMed: 12112484] 
Montgomery C, Pocock M, Titley K, Lloyd K. Predicting psychological distress in patients with 
leukemia and lymphoma. Journal of Psychosomatic Research. 2003; 54:289–292. DOI: 10.1016/
S0022-3999(02)00396-3 [PubMed: 12670604] 
National Cancer Institute. General information about adult acute lymphoblastic leukemia. 2014a. 
Retrieved from http://www.cancer.gov/cancertopics/pdq/treatment/adultALL/Patient/page1
National Cancer Institute. General information about adult acute myeloid leukemia. 2014b. Retrieved 
from http://www.cancer.gov/cancertopics/pdq/treatment/adultAML/Patient/page1
National Cancer Institute. SEER stat fact sheets: Leukemia. 2014c. Retrieved from http://
seer.cancer.gov/statfacts/html/leuks.html
Bryant et al. Page 8













National Coalition for Cancer Survivorship. Survivorship definitions. 2004. Retrieved from http://
cancercontrol.cancer.gov/ocs/statistics/definitions.html
Persson L, Hallberg I. Lived experience of survivors of leukemia or malignant lymphoma. Cancer 
Nursing. 2004; 27:303–313. DOI: 10.1097/00002820-200407000-00007 [PubMed: 15292726] 
Persson L, Larsson G, Ohlsson O, Hallberg I. Acute leukaemia or highly malignant lymphoma 
patients’ quality of life over two years: A pilot study. European Journal of Cancer Care. 2001; 
10:36–47. DOI: 10.1046/j.1365-2354.2001.00236.x [PubMed: 11827266] 
Pearce M, Coan A, Herndon J, Koenig H, Abernethy A. Unmet spiritual care needs impact emotional 
and spiritual wellbeing in advanced cancer patients. Supportive Care in Cancer. 2012; 20:2269–
2276. DOI: 10.1007/s00520-011-1335-1 [PubMed: 22124529] 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The PRISMA statement. 2014. 
Retrieved from http://prisma-statement.org/statement.htm
Sekeres MA, Stone RM. The challenge of acute myeloid leukemia in older patients. Current Opinions 
in Oncology. 2002; 14:24–30. DOI: 10.1097/00001622-200201000-00005
Schumacher A, Kessler T, Buchner T, Wewers D, van de Loo J. Quality of life in adult patients with 
acute myeloid leukemia receiving intensive and prolonged chemotherapy—A longitudinal study. 
Leukemia. 1998; 12:586–592. DOI: 10.1038/sj.leu.2400977 [PubMed: 9557618] 
Stalfelt A. Quality of life of patients with acute myeloid leukemia. Leukemia Research. 1994; 18:257–
267. DOI: 10.1016/0145-2126(94)90028-0 [PubMed: 8170170] 
Stone R. The difficult problem of acute myeloid leukemia in the older adult. CA: A Cancer Journal for 
Clinicians. 2002; 52:363–371. DOI: 10.3322/canjclin.52.6.363 [PubMed: 12469764] 
Stone RM, Mayer RJ. Treatment of the newly diagnosed adult with de novo acute myeloid leukemia. 
Hematology/Oncology Clinics of North America. 1993; 7:47–64. [PubMed: 8449864] 
Xuereb MC, Dunlop R. The experience of leukaemia and bone marrow transplant: Searching for 
meaning and agency. Psycho-Oncology. 2003; 12:397–409. [PubMed: 12833554] 
Yau E, Rohatiner A, Lister T, Hinds C. Long term prognosis and quality of life following intensive 
care for life-threatening complications of haematological malignancy. British Journal of Cancer. 
1991; 64:938–942. [PubMed: 1931620] 
Appendix A
Reviewed Studies



































than age 60, 

































estimates of the 
effects of exercise 
Bryant et al. Page 9













Study Purpose Domains Sample Design and Instruments Findings
on QOL and 
fatigue, and to 
understand the 
impact of exercise 
















To examine QOL 
and self-reported 
functional status 
over a six-month 
period in older 
















with a mean 



































ADL scores did 










does not appear 
































with a mean 



























Bryant et al. Page 10
































































were noted in 
cardiorespiratory 
endurance (p = 
0.009; baseline, 








scores also were 
noted (p = 
0.009; baseline, 






reduced as well 
































followed up in a 
prospective study
• Symptoms 119 patients 
in Italy with 
various 
cancers and 
a mean age 









survival of the 
entire cohort 
was 4.8 months 




baseline by 91% 






Bryant et al. Page 11






















were found for 
curable versus 
terminal, 0.055 
(95% CI [0.022, 
0.136], p < 
0.001), and for 
advanced versus 
terminal, 0.193 
(95% CI [0.103, 







survival with an 
HR of 1.801 
(95% CI [1.044, 









identified in this 
study.
















with a mean 





with a mean 





















Klepin et al., 
2011
To test feasibility 
and use of a 































the entire GA; 
the mean time 
was 44 minutes 













Bryant et al. Page 12







































years [SD = 










of having a high 
distress score on 
the BSI was 
almost twice 
that of acute 
leukemia 
survivors (OR = 
1.9), with 21% 
of Hodgkin 
versus 14% of 
acute leukemia 
survivors (p < 
0.05) having 
scores that were 
1.5 SDs above 
the norm, 








fatigue, p = 0.01, 





CINV (p < 
0.05), greater 
impact of cancer 
on their family 
life (p = 0.004), 
and poorer 
sexual 










QOL, fatigue, and 
physical function 
in patients with 
acute leukemia; 
and to compare 
changes in 
physical function, 
QOL, and fatigue 
in older (aged 60 














than age 60 
(68% male) 
and 38 were 






















QOL was fairly 
stable over time 
and similar in 
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Study Purpose Domains Sample Design and Instruments Findings
chemotherapy 







To evaluate the 
clinical 




Weighting, in a 









with a mean 



























(82%) as an 
important area 
from which 
QOL is derived; 
this domain was 
also weighted by 
58% of patients 
as first or second 
in importance. 
The fact that 
“health,” as a 
domain, was not, 








value of using 
an instrument 












anxiety is an 
important risk 
factor for a 
diminished QOL 
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style, QOL, and 
psychological 
distress in a 










with a mean 


















poorly to their 
diagnosis and 
having low 
scores on the 
Fighting Spirit 
subscale of the 
MAC and high 




with a worse 
coping style 
were most likely 




Pearce et al., 
2012




their needs. When 
inconsistent, are 
there deleterious 










a mean age 

























[adjusted β (SE) 
0–1.2 (0.47), p = 
0.013] and less 
meaning and 
peace [adjusted 
β (SE) 0–2.37 










lymphoma at the 
start of treatment 
and during two 
years. The 
secondary aim 














with a mean 






QOL at start of 
treatment was 
reduced mostly 
with role and 
social 
functioning and 





relapsed at the 
start of 
treatment had a 
significantly 
more reduced 
QOL in most 
functional 
aspects and a 
higher level for 
most symptoms 
compared to 
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Study Purpose Domains Sample Design and Instruments Findings


















To narrate the 
lived experience 
of falling ill, 
being in 
treatment, and life 
following this 
event





with a mean 







• Interview (a) Believed in 
life, fought for 
it, and came 
through 
stronger; (b) life 
went on, adapted 
and found a 
balance in the 
new life; and (c) 
life was over, 
felt out of 




To evaluate QOL 
in patients with 
acute leukemia 
treated according 
to the protocol of 



































Stalfelt, 1994 To explore QOL 
in patients with 
acute leukemia 




































regard to what 
was important in 
their lives. They 
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Study Purpose Domains Sample Design and Instruments Findings




































QOL of six of 
the seven long-
term survivors is 
good, while that 
of the other is 
acceptable. 






had returned to 
full-time 
employment, 
and all seven 
stated that they 
would be willing 
to undergo 
intensive care 
again under the 
same 
circumstances.
ADL—activities of daily living; BSI—Beck Symptom Inventory; CES-D—Center for Epidemiologic Studies Depression; 
CI—confidence interval; CINV—chemotherapy-induced nausea and vomiting; DT—Distress Thermometer; ESAS—
Edmonton Symptom Assessment Scale; EORTC QLQ-C30—European Organisation for the Research and Treatment of 
Cancer Quality of Life Questionnaire–Core 30; FACT-F—Functional Assessment of Cancer Therapy–Fatigue; FACT-G—
Functional Assessment of Cancer Therapy–General; FACT-Sp—Functional Assessment of Cancer Therapy–Spiritual; FLIC
—Functional Living Index-Cancer; GA—geriatric assessment; GDS—Geriatric Depression Scale; HADS—Hospital 
Anxiety and Depression Scale; HR—hazard ratio; ICU—intensive care unit; LIP—Life Ingredient Profile; LGC—Lund 
Gerontological Centre Generic Global QOL; MAC—Mental Adjustment to Cancer; MDASI—MD Anderson Symptom 
Inventory; PAIS-SR—Psychosocial Adjustment to Illness Scale–Self Report; PQOL—Perceived Quality of Life; QOL—
quality of life; RPFS—Revised Piper Fatigue Scale; SEIQOL—Schedule for the Evaluation of Individual Quality of Life; 
VAS—Visual Analog Scale
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Using qualitative methods to complement standard quality-of-life (QOL)–related 
instruments would more adequately capture the totality of a survivor’s experience than 
one measure alone.
Emphasis should be placed on evidence-based resources for common symptoms, such as 
fatigue and depression.
Future studies that explore trajectories of symptoms and QOL in adult survivors will 
provide important data for interventional work.
Bryant et al. Page 18














Search and Selection Criteria in Accordance With PRISMA Guidelines
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